• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性缺血性卒中的再灌注治疗:新时代的曙光?

Reperfusion therapy in acute ischemic stroke: dawn of a new era?

作者信息

Bhaskar Sonu, Stanwell Peter, Cordato Dennis, Attia John, Levi Christopher

机构信息

Western Sydney University (WSU), School of Medicine, South West Sydney Clinical School, Sydney, NSW, 2170, Australia.

Liverpool Hospital, Department of Neurology & Neurophysiology, Liverpool, 2170, NSW, Australia.

出版信息

BMC Neurol. 2018 Jan 16;18(1):8. doi: 10.1186/s12883-017-1007-y.

DOI:10.1186/s12883-017-1007-y
PMID:29338750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5771207/
Abstract

Following the success of recent endovascular trials, endovascular therapy has emerged as an exciting addition to the arsenal of clinical management of patients with acute ischemic stroke (AIS). In this paper, we present an extensive overview of intravenous and endovascular reperfusion strategies, recent advances in AIS neurointervention, limitations of various treatment paradigms, and provide insights on imaging-guided reperfusion therapies. A roadmap for imaging guided reperfusion treatment workflow in AIS is also proposed. Both systemic thrombolysis and endovascular treatment have been incorporated into the standard of care in stroke therapy. Further research on advanced imaging-based approaches to select appropriate patients, may widen the time-window for patient selection and would contribute immensely to early thrombolytic strategies, better recanalization rates, and improved clinical outcomes.

摘要

随着近期血管内治疗试验的成功,血管内治疗已成为急性缺血性卒中(AIS)患者临床管理手段中的一项令人振奋的补充。在本文中,我们对静脉和血管内再灌注策略、AIS神经介入的最新进展、各种治疗模式的局限性进行了全面概述,并对影像引导下的再灌注治疗提供见解。还提出了AIS影像引导下再灌注治疗工作流程的路线图。全身溶栓和血管内治疗均已纳入卒中治疗的护理标准。对基于先进影像的方法进行进一步研究以选择合适的患者,可能会扩大患者选择的时间窗,并将极大地有助于早期溶栓策略、提高再通率和改善临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4941/5771207/1fc1162448a9/12883_2017_1007_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4941/5771207/3887cee198d1/12883_2017_1007_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4941/5771207/1fc1162448a9/12883_2017_1007_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4941/5771207/3887cee198d1/12883_2017_1007_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4941/5771207/1fc1162448a9/12883_2017_1007_Fig2_HTML.jpg

相似文献

1
Reperfusion therapy in acute ischemic stroke: dawn of a new era?急性缺血性卒中的再灌注治疗:新时代的曙光?
BMC Neurol. 2018 Jan 16;18(1):8. doi: 10.1186/s12883-017-1007-y.
2
Thrombolysis and reperfusion: advanced understanding of early management strategies in acute ischemic stroke.溶栓与再灌注:对急性缺血性卒中早期管理策略的深入理解
Neurol Res. 2014 May;36(5):391-6. doi: 10.1179/1743132814Y.0000000349. Epub 2014 Mar 25.
3
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
4
The era after DAWN: treatment of acute ischaemic stroke.DAWN之后的时代:急性缺血性卒中的治疗
Hong Kong Med J. 2018 Jun;24(3):313-315. doi: 10.12809/hkmj176912.
5
Reperfusion therapies for acute ischemic stroke: an update.急性缺血性卒中的再灌注治疗:最新进展
Curr Cardiol Rev. 2014 Nov;10(4):327-35. doi: 10.2174/1573403x10666140320144637.
6
History, Evolution, and Importance of Emergency Endovascular Treatment of Acute Ischemic Stroke.急性缺血性脑卒中的急诊血管内治疗的历史、演变和重要性。
Curr Neurol Neurosci Rep. 2016 May;16(5):42. doi: 10.1007/s11910-016-0646-5.
7
Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial.阿尔伯塔省卒中计划早期 CT 评分选择血管内治疗患者:介入性卒中治疗(IMS)-III 试验。
Stroke. 2014 Feb;45(2):444-9. doi: 10.1161/STROKEAHA.113.003580. Epub 2013 Dec 12.
8
Acute endovascular recanalization therapy in wake-up stroke.急性血管内再通治疗在唤醒性卒中中的应用。
J Neurol Sci. 2011 Jan 15;300(1-2):148-50. doi: 10.1016/j.jns.2010.10.019.
9
Endovascular reperfusion therapy for acute ischemic stroke: a meta-analysis.急性缺血性卒中的血管内再灌注治疗:一项荟萃分析。
Neurol Res. 2010 Oct;32(8):787-91. doi: 10.1179/174313209X382430.
10
Acute stroke intervention: a systematic review.急性脑卒中干预:系统评价。
JAMA. 2015 Apr 14;313(14):1451-62. doi: 10.1001/jama.2015.3058.

引用本文的文献

1
Causal Association of Free Triiodothyronine Level with Ischemic Stroke Outcome: A Mendelian Randomization Study.游离三碘甲状腺原氨酸水平与缺血性卒中结局的因果关联:一项孟德尔随机化研究。
Life (Basel). 2025 Aug 16;15(8):1303. doi: 10.3390/life15081303.
2
Comparative Efficacy and Safety of Different Tenecteplase Doses With Alteplase in Acute Ischemic Stroke: A Systematic Review With Pairwise and Network Meta-Analysis to Determine the Optimal Dose.不同剂量替奈普酶与阿替普酶治疗急性缺血性卒中的疗效和安全性比较:一项采用成对和网状Meta分析以确定最佳剂量的系统评价
Brain Behav. 2025 Aug;15(8):e70756. doi: 10.1002/brb3.70756.
3
Hydrogel-based biomaterials for brain regeneration after stroke: Gap to clinical translation.

本文引用的文献

1
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.发病后 6 至 24 小时内进行取栓术治疗与缺损和梗死不匹配的脑卒中。
N Engl J Med. 2018 Jan 4;378(1):11-21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11.
2
A New DAWN for Imaging-Based Selection in the Treatment of Acute Stroke.基于成像的急性卒中治疗选择的新曙光。
N Engl J Med. 2018 Jan 4;378(1):81-83. doi: 10.1056/NEJMe1713367. Epub 2017 Nov 11.
3
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).
用于中风后脑再生的水凝胶基生物材料:向临床转化的差距
Biomater Transl. 2025 Jun 25;6(2):165-180. doi: 10.12336/bmt.24.00020. eCollection 2025.
4
A minimally invasive thrombotic model to study stroke in awake mice.一种用于研究清醒小鼠中风的微创血栓形成模型。
Nat Commun. 2025 May 10;16(1):4356. doi: 10.1038/s41467-025-59617-1.
5
Clemastine Reduces post-stroke Neurodegeneration by Alleviating Endoplasmic Reticulum stress-mediated Demyelination and Cognitive Impairment Through PERK/ATF4/CHOP Signaling Pathway.氯马斯汀通过PERK/ATF4/CHOP信号通路减轻内质网应激介导的脱髓鞘和认知障碍,从而减少中风后的神经退行性变。
Neurochem Res. 2025 Apr 25;50(3):151. doi: 10.1007/s11064-025-04403-0.
6
Cynaroside: a potential therapeutic agent targeting arachidonate 15-lipoxygenase to mitigate cerebral ischemia/reperfusion injury.木犀草苷:一种靶向花生四烯酸15-脂氧合酶以减轻脑缺血/再灌注损伤的潜在治疗剂。
Front Neurol. 2025 Feb 14;15:1490640. doi: 10.3389/fneur.2024.1490640. eCollection 2024.
7
Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS): A Comprehensive Meta-Analysis of Ethnicity, Socioeconomic Status, and Geographical Factors.急性缺血性中风再灌注治疗可及性差异(DARTS):种族、社会经济地位和地理因素的综合荟萃分析
CNS Drugs. 2025 Apr;39(4):417-442. doi: 10.1007/s40263-025-01161-z. Epub 2025 Feb 15.
8
HS Donor SPRC Ameliorates Ischemic Stroke by Upregulating CD24.造血干细胞捐献者来源的间充质干细胞通过上调CD24改善缺血性中风。
CNS Neurosci Ther. 2025 Feb;31(2):e70243. doi: 10.1111/cns.70243.
9
Investigation into the Potential Mechanism of Radix Paeoniae Rubra Against Ischemic Stroke Based on Network Pharmacology.基于网络药理学对赤芍抗缺血性脑卒中潜在机制的研究
Nutrients. 2024 Dec 23;16(24):4409. doi: 10.3390/nu16244409.
10
Xinnaotongluo liquid protects H9c2 cells against hypoxic damage through IRF2/HIF-1α-mediated oxidation, inflammation, and apoptosis.心脑通络液通过IRF2/HIF-1α介导的氧化、炎症和凋亡保护H9c2细胞免受缺氧损伤。
Histol Histopathol. 2025 Aug;40(8):1287-1294. doi: 10.14670/HH-18-855. Epub 2024 Nov 28.
多中心随机对照试验的血管内治疗后的影像学评估缺血性脑卒中(DEFUSE 3)。
Int J Stroke. 2017 Oct;12(8):896-905. doi: 10.1177/1747493017701147. Epub 2017 Mar 24.
4
Dawn of an Even Newer Era: Mechanical Thrombectomy for Acute Ischemic Stroke Beyond 6 to 8 Hours.一个更新时代的黎明:6至8小时以上急性缺血性卒中的机械取栓术
World Neurosurg. 2017 Aug;104:968-969. doi: 10.1016/j.wneu.2017.06.102. Epub 2017 Jun 20.
5
The Impact of Conscious Sedation versus General Anesthesia for Stroke Thrombectomy on the Predictive Value of Collateral Status: A Post Hoc Analysis of the SIESTA Trial.清醒镇静与全身麻醉用于卒中取栓术对侧支循环状态预测价值的影响:SIESTA试验的事后分析
AJNR Am J Neuroradiol. 2017 Aug;38(8):1580-1585. doi: 10.3174/ajnr.A5243. Epub 2017 Jun 8.
6
General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The AnStroke Trial (Anesthesia During Stroke).全身麻醉与清醒镇静用于急性缺血性卒中血管内治疗的比较:AnStroke试验(卒中期间的麻醉)
Stroke. 2017 Jun;48(6):1601-1607. doi: 10.1161/STROKEAHA.117.016554.
7
Combined Intravenous Thrombolysis and Thrombectomy vs Thrombectomy Alone for Acute Ischemic Stroke: A Pooled Analysis of the SWIFT and STAR Studies.联合静脉溶栓与血管内取栓治疗与单纯血管内取栓治疗急性缺血性脑卒中的对比:SWIFT 和 STAR 研究的汇总分析。
JAMA Neurol. 2017 Mar 1;74(3):268-274. doi: 10.1001/jamaneurol.2016.5374.
8
Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke).Solitaire支架取栓术治疗急性缺血性卒中的成本效益:SWIFT-PRIME试验(以取栓术为急性缺血性卒中主要血管内治疗手段的Solitaire)结果
Stroke. 2017 Feb;48(2):379-387. doi: 10.1161/STROKEAHA.116.014735. Epub 2016 Dec 27.
9
Mechanical Thrombectomy Using the Trevo ProVue in 50 Consecutive Patients with Anterior Circulation Stroke: A Single-Center Experience after Approval of the Stent Retriever in Japan.连续50例前循环卒中患者使用Trevo ProVue进行机械取栓术:日本批准支架取栓器后的单中心经验。
Neurol Med Chir (Tokyo). 2017 Mar 15;57(3):128-135. doi: 10.2176/nmc.oa.2016-0215. Epub 2016 Dec 27.
10
The Penumbra 5MAX ACE Catheter Is Safe, Efficient, and Cost Saving as a Primary Mechanical Thrombectomy Device for Large Vessel Occlusions in Acute Ischemic Stroke.Penumbra 5MAX ACE导管作为急性缺血性卒中大血管闭塞的主要机械取栓装置,安全、高效且节省成本。
Ochsner J. 2016 Winter;16(4):486-491.